A recent study by Klaver et al. demonstrated that nearly one third of liposarcomas and leiomyosarcomas belong to the CD8+ T cell-poor tumors, whereas pleomorphic sarcoma and myxofibrosarcoma were shown to have one of the highest infiltration with CD8+ T cells [48]. This evidence concerns the gene CD8A and leiomyosarcoma.